Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00303342 · ClinicalTrials.gov registry record · Phase 2

Neuroendocrine Mechanisms in Behavioral Treatment of Insomnia

A Phase 2 study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
Phase 2
Development phase
60
Enrollment target

NCT00303342: Completed Phase 2 study, sponsored by Brigham and Women's Hospital.

NCT00303342 is a Phase 2 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 60 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00303342, a Phase 2 study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
Phase 2
Development phase
60 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the change in measures of physiological arousal before and after behavioral treatment of insomnia.

Interventions

  • BEHAVIORAL mind body treatment
  • BEHAVIORAL desensitization

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2006-03
Est. Completion 2009-06
Phase Phase 2
Brigham and Women's Hospital

937 total trials

What the finished NCT00303342 record still lists

NCT00303342 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower).

The record links to 0 conditions, and to 2 interventions - of which mind body treatment is the first listed.

NCT00303342 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00303342 about?

NCT00303342 is a clinical study titled "Neuroendocrine Mechanisms in Behavioral Treatment of Insomnia". The purpose of this study is to evaluate the change in measures of physiological arousal before and after behavioral treatment of insomnia.

What is the current status of trial NCT00303342?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2006-03. Estimated completion is 2009-06.

What interventions are being tested in trial NCT00303342?

The interventions under investigation include: mind body treatment (BEHAVIORAL), desensitization (BEHAVIORAL).

Who is sponsoring clinical trial NCT00303342?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00303342's enrollment target sits among peer trials

60 1027th of 2000 higher than 868 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00303342, the US trial registry maintained by the National Library of Medicine. NCT00303342 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.